CareDx to Participate in Upcoming Investor Conferences

Tuesday, August 15, 2017 12:00 PM UTC

BRISBANE, Calif., Aug. 15, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, PhD., Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in four upcoming investor conferences.

Piper Jaffray Bus Tour in Palo Alto, CA

Dr. Peter Maag and Michael Bell will participate on Wednesday, August 23, 2017
at 9:30am PT/12:30pm ET

Southern California Investor Conference in Newport Beach, CA

Dr. Peter Maag will present on Thursday, August 24, 2017 at 10:30am PT/1:30pm ET

Rodman & Renshaw 19^th Annual Global Investment Conference in New York City

Dr. Peter Maag will present on Monday, September 11, 2017 at 12:00pm PT/3:00pm ET

Cantor Fitzgerald Global Healthcare Conference in New York City

Dr. Peter Maag will present on Tuesday, September 26, 2017 at 12:25pm PT/3:25pm ET

Live audio webcasts of Southern California Investor, Rodman & Renshaw Global Investment and Cantor Fitzgerald Global Health conferences will be available online from the investor relations page of the Company's website at http://investors.caredxinc.com. The webcast replays of the presentations will begin approximately one hour after the conclusion of the live presentations and will be available on the Company's website for 90 days. Due to the one-on-one only format of the Piper Jaffray Bus Tour, no webcast will be available.

About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products across the transplant testing continuum, including AlloMap® and AlloSure™ for post-transplant surveillance and Olerup SSP®, Olerup QTYPE®, and Olerup SBT™ for pre-transplant HLA testing.

For more information, please visit: www.CareDx.com.

Investor Contact
Sasha King, Chief Commercial Officer
T: +1 415-287-2393
E: [email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

CareDx to Participate in Upcoming Investor Conferences

Editor's Picks

Welcome to EconoTimes